Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Alnylam Pharmaceuticals Inc., 3 years.
Alnylam Pharmaceuticals Inc.
Director
Vir Biotechnology Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 29, 2024 | Alnylam Pharmaceuticals Inc. | Option exercise | +30,000 | $59.25 | $1,777,500 |
| Feb 29, 2024 | Alnylam Pharmaceuticals Inc. | Open-market sale | −13,005 | $150.60 | $1,958,553 |
| Feb 29, 2024 | Alnylam Pharmaceuticals Inc. | Open-market sale | −13,557 | $151.43 | $2,052,937 |
| Feb 29, 2024 | Alnylam Pharmaceuticals Inc. | Open-market sale | −915 | $152.40 | $139,446 |
| Feb 29, 2024 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,906 | $153.62 | $292,800 |
| Feb 29, 2024 | Alnylam Pharmaceuticals Inc. | Open-market sale | −101 | $154.07 | $15,561 |
| Feb 29, 2024 | Alnylam Pharmaceuticals Inc. | Open-market sale | −516 | $156.54 | $80,775 |
| May 22, 2023 | Vir Biotechnology Inc. | Grant or award | +6,027 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.